These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Serotonin as mediator in vomiting reflex: effect of a serotonin3 receptor antagonist in chemotherapy-induced vomiting]. Layer P. Z Gastroenterol; 1991 May; 29(5):265-6. PubMed ID: 1835227 [No Abstract] [Full Text] [Related]
4. [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)]. Erben M. Wien Klin Wochenschr; 1991 May; 103(19):594-601. PubMed ID: 1836917 [No Abstract] [Full Text] [Related]
5. Ondansetron--the first of a new class of antiemetic agents. Chaffee BJ, Tankanow RM. Clin Pharm; 1991 Jun; 10(6):430-46. PubMed ID: 1829668 [Abstract] [Full Text] [Related]
15. Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs. McMillan C, Dundee JW, Abram WP. Br J Cancer; 1991 Nov; 64(5):971-2. PubMed ID: 1834156 [No Abstract] [Full Text] [Related]
16. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes. Schmoll HJ. Eur J Cancer Clin Oncol; 1989 Nov; 25 Suppl 1():S35-9. PubMed ID: 2533897 [Abstract] [Full Text] [Related]
19. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial. Mantovani G, Macciò A, Bianchi A, Curreli L, Ghiani M, Proto E, Santona MC. Cancer; 1996 Mar 01; 77(5):941-8. PubMed ID: 8608488 [Abstract] [Full Text] [Related]